Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats

British Journal of Pharmacology

Volumn 119, Issue 5, 1996, Pages 845-850

  Assié, Marie Bernadette ^a   Koek, Wouter ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

5 HT reuptake; 8 hydroxy 2 (di n propylamino)tetralin (8 OH DPAT); Extracellular 5 HT concentration; Hippocampus; Microdialysis

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; CLOMIPRAMINE; FENFLURAMINE; FLESINOXAN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1A AGONIST; SEROTONIN UPTAKE INHIBITOR; TRITIUM;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPUS; ISOTOPE LABELING; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029921978     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15749.x     Document Type: Article

References (31)

1. ADELL, A., CARCELLER, A. & ARTIGAS, F. (1993). In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: Effects of 8-hydroxy-2-(di-n-propylamino)tetralin. J. Neurochem., 60, 1673-1681.
2. 1A binding site in the rat striatum. J. Pharm. Pharmacol., 40, 888-891.
3. 1B receptors. Neuropharmacolagy, 35, 213-222.
4. ASSIE, M.-B. & KOEK, W. (1996b). 8-OH-DPAT may have 5-HT uptake blocking properties in rat hippocampus. Br. J. Pharmacol., 117, 92P.
5. 1A receptor antagonists on hippocampal 5-HT levels: (S)-WAY-100135, but not WAY-100635, has partial agonist properties. Eur. J. Pharmacol., 304, 15-21.
6. AUERBACH, S.B., LUNDBERG, J.F. & HJORTH, S. (1995). Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration. Neuropharmacology, 34, 89-96.
7. BENVENISTE, H. (1989). Brain microdialysis. J. Neurochem., 52, 1667-1679.
8. BOSKER, F., KLOMPMAKERS, A. & WESTENBERG, H. (1994). Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin and is sensitive to tetrodotoxin. J. Neurochem., 63, 2165-2171.
9. 1A receptors. J. Neurochem., 66, 2546 2555.
10. 3H]5-hydroxytryptamine into rat cortical synaptosomes. Eur. J. Pharmacol., 239, 211-214.
11. DELEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous , analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235, E97-E112.
12. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol., 281, 81-88.
13. FULLER, R.W. (1994). Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci., 55, 163-167.
14. 1A receptor antagonist WAY-100635 on hippocampal 5-HT release in vivo. Br. J. Pharmacol., 112, 299P.
15. HAMON, M., BOURGOIN, S., GOZLAN, H., HALL, M.D., GOETZ, C., ARTAUD, F. & HORN, A.S. (1984). Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)-tetralin) in the rat brain. Eur. J. Pharmacol., 100, 263-276.
16. 3H]8-OH-DPAT labels the 5-HT transporter in human platelets. Life Sci., 42, 311-320.
17. 1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther., 269, 1268-1279.
18. KREISS, D.S., WIELAND, S. & LUCKI, I (1993). The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience. 52, 295-301.
19. LAFERRERE, B. & WURTMAN, R.J. (1989). Effect of D-fenfluramine on serotonin release in brains of anaesthetized rats. Brain Res., 504, 258-263.
20. PAXINOS G. & WATSON, C.(1986). The Rat Brain in Stereolaxic Coordinates. 2nd Ed. New York: Academic Press.
21. SABOL, K.E., RICHARDS, J.B. & SEIDEN, L.S. (1992). Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Res., 585, 421-424.
22. SARKISSIAN, C.F., WURTMAN, R.J., MORSE, A.N. & GLEASON, R. (1990). Effects of fluoxetine or D-fenfluramine on serotonin release from, and levels in, rat frontal cortex. Brain Res., 529, 294-301.
23. SCHIPPER, J., TULP, M.TH.M., BERKELMANS, B., MOS, J., VAN DER HEIJDEN, J.A.M. & OLIVIER, B. (1991). Preclinical pharmacology of flesinoxan: a potential anxiolytic and antidepressant drug. Hum. Psychopharmacol., 6, S53-S61.
24. 3H]8-OH-DPAT labels the serotonin transporter in the rat striatum. Eur. J. Pharmacol., 124, 371-373.
25. SERIES, H.G., COWEN, P.J. & SHARP, T. (1994). p-Chloroamphetamine (PCA), 3,4-methylenedioxymethamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology, 116, 508-514.
26. SHARP, T., BRAMWELL, S.R., CLARK, D. & GRAHAME-SMITH, D.G. (1989a). In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem., 53, 234-240.
27. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmacol., 96, 283-290.
28. 1A autoreceptor. J. Neurosci. Methods, 34, 83-90.
29. 3H]8-OH-DPAT labeling of serotonin uptake sites. Brain Res., 617, 159-162.
30. THOMAS, D.R., NELSON, D.R. & JOHNSON, A.M. (1987). Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology, 93, 193-200.
31. WOLF, W.A. & KUHN, D.M. (1991). The 5-HT transporter is an additional site of action for the 5-HT agonists RU 24969 and TFMPP. Neurochem. Int., 19, 39-44.